In March 2008, Takeda and Abbott Laboratories announced plans to conclude their 30-year-old joint venture, TAP Pharmaceuticals, that had over USD3 billion in sales in its final year.
I marts 2008 besluttede Takeda og Abbott Laboratories at afslutte deres 30-årige joint venture, TAP Pharmaceuticals, som havde en omsætning på over 3 mia. USD.